| PUBCHEM ID | 1549108 |
| Molecular Weight (mg/mol) | 222.366 |
| Molecular Formula | C15H26O |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 7 |
| IUPAC Name | (2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol |
| Canonical SMILES | C/C(C)=CCC/C(C)=C/CC/C(C)=C/CO |
| PUBCHEM IUPAC INCHIKEY | CRDAMVZIKSXKFV-PVMFERMNSA-N |
| Solubility Level | 3 |
| Vapour Pressure | -3.325 |
| XLOGP3 AA | 4.8 |
| CACTVS TPSA | 20.2 |
| BBB Level | 0 |
| Absorption Level | 0 |
| EXT PPB#Prediction | 1 |
| AlogP98 | 4.76 |
| EXT CYP2D6#Prediction | 0 |
| Mouse Female FDA | Non-Carcinogen |
| Mouse Male FDA | Multi-Carcinogen |
| Rat Female FDA | Single-Carcinogen |
| Rat Male FDA | Multi-Carcinogen |
| Ames Prediction | Non-Mutagen |
| Developmental / Reproductive Toxicity | Toxic |
| Rat Oral LD50 | 5.96636 g/kg_body_weight |
| Ocular Irritancy | None |
| Hepatotoxic#Prediction | 0 |
| Effected Human Genes | NR1H4, RDH16, ISYNA1,HMGCR, MAOB, AKR1B10, AKR1C3, IVL, CACNA1B,MVK, PCYT1A,FDFT1, RHOA, RELA, IL6, NR1H2, ESR1, NR1H3, MAP2K1, MAPK1, GSR, PPARA, NFKB1, BAK1, TLR6 |
| Aerobic Biodegradability Prediction | Degradable |
| Physical hazards | not classified |
| Health hazards | Moderate |
| Environmental hazards | not classified |
| Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
|---|---|---|---|---|---|---|
| 1 | 3790-71-4 | NR1H4, RDH16, ISYN | Candida albicans | 2812148 | ||
| 2 | 3790-71-4 | NR1H4, RDH16, ISYN | Candida albicans | 2812148 |
| Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
|---|---|---|---|---|---|
| 1 | Anti-microbial | 63 | 3790-71-4 | (22)-(6e)-Farnesol |
| Serial No. | Plant Name | Variety Name | Essential Oil | Compound Percentage |
|---|---|---|---|---|
| 1 | Lavendula angustifolia | Sher-e-Kashmir | Lavandula angustifolia sher-e-Kashmir essential oil |